Related references
Note: Only part of the references are listed.In Vitro Activity of Imipenem-Relebactam against Clinical Isolates of Gram-Negative Bacilli Isolated in Hospital Laboratories in the United States as Part of the SMART 2016 Program
James A. Karlowsky et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Antimicrobial activity of ceftolozane-tazobactam tested against Enterobacteriaceae and Pseudomonas aeruginosa collected from patients with bloodstream infections isolated in United States hospitals (2013-2015) as part of the Program to Assess Ceftolozane-Tazobactam Susceptibility (PACTS) surveillance program
Dee Shortridge et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2018)
Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis
Evelina Tacconelli et al.
LANCET INFECTIOUS DISEASES (2018)
Antimicrobial Activity of Ceftolozane-Tazobactam Tested Against Enterobacteriaceae and Pseudomonas aeruginosa with Various Resistance Patterns Isolated in US Hospitals (2013-2016) as Part of the Surveillance Program: Program to Assess Ceftolozane-Tazobactam Susceptibility
Dee Shortridge et al.
MICROBIAL DRUG RESISTANCE (2018)
The Therapeutic Pipeline for Pseudomonas aeruginosa Infections
Lori L. Burrows
ACS INFECTIOUS DISEASES (2018)
Carbapenem-Nonsusceptible Gram-Negative Pathogens in ICU and Non-ICU Settings in US Hospitals in 2017: A Multicenter Study
Eilish McCann et al.
OPEN FORUM INFECTIOUS DISEASES (2018)
Activity of Ceftolozane-Tazobactam against Pseudomonas aeruginosa and Enterobacteriaceae Isolates Collected from Respiratory Tract Specimens of Hospitalized Patients in the United States during 2013 to 2015
Mariana Castanheira et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia
Antoni Torres et al.
EUROPEAN RESPIRATORY JOURNAL (2017)
Results of a local combination therapy antibiogram for Pseudomonas aeruginosa isolates: is double worth the trouble?
Matthew Song et al.
THERAPEUTIC ADVANCES IN INFECTIOUS DISEASE (2017)
Results from a 13-Year Prospective Cohort Study Show Increased Mortality Associated with Bloodstream Infections Caused by Pseudomonas aeruginosa Compared to Other Bacteria
Joshua T. Thaden et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016
Andrew Rhodes et al.
CRITICAL CARE MEDICINE (2017)
Performance characteristics and associated outcomes for an automated surveillance tool for bloodstream infection
Jessica P. Ridgway et al.
AMERICAN JOURNAL OF INFECTION CONTROL (2016)
Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society
Andre C. Kalil et al.
CLINICAL INFECTIOUS DISEASES (2016)
Antimicrobial-Resistant Pathogens Associated With Healthcare-Associated Infections: Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2011-2014
Lindsey M. Weiner et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2016)
Antimicrobial Stewardship in the Microbiology Laboratory: Impact of Selective Susceptibility Reporting on Ciprofloxacin Utilization and Susceptibility of Gram-Negative Isolates to Ciprofloxacin in a Hospital Setting
B. J. Langford et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2016)
Pseudomonas aeruginosa Nosocomial Pneumonia: Impact of Pneumonia Classification
Scott T. Micek et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2015)
Restrictive reporting of selected antimicrobial susceptibilities influences clinical prescribing
Jaffar A. Al-Tawfiq et al.
JOURNAL OF INFECTION AND PUBLIC HEALTH (2015)
An international multicenter retrospective study of Pseudomonas aeruginosa nosocomial pneumonia: impact of multidrug resistance
Scott T. Micek et al.
CRITICAL CARE (2015)
Imipenem, Meropenem, or Doripenem To Treat Patients with Pseudomonas aeruginosa Ventilator-Associated Pneumonia
Charles-Edouard Luyt et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Pseudomonas aeruginosa Biofilms in Disease
Lawrence R. Mulcahy et al.
MICROBIAL ECOLOGY (2014)
Weighted-incidence syndromic combination antibiograms to guide empiric treatment of critical care infections: a retrospective cohort study
Varinder Randhawa et al.
CRITICAL CARE (2014)
Multi-drug resistance, inappropriate initial antibiotic therapy and mortality in Gram-negative severe sepsis and septic shock: a retrospective cohort study
Marya D. Zilberberg et al.
CRITICAL CARE (2014)
Attributable Burden of Hospital-Onset Clostridium difficile Infection: A Propensity Score Matching Study
Ying P. Tabak et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2013)
Impact of adequate empirical combination therapy on mortality from bacteremic Pseudomonas aeruginosa pneumonia
So-Youn Park et al.
BMC INFECTIOUS DISEASES (2012)
Combination Therapy for Treatment of Infections with Gram-Negative Bacteria
Pranita D. Tamma et al.
CLINICAL MICROBIOLOGY REVIEWS (2012)
Role of Unit-Specific Combination Antibiograms for Improving the Selection of Appropriate Empiric Therapy for Gram-Negative Pneumonia
Jason M. Pogue et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2011)
Monotherapy or Combination Therapy? The Pseudomonas aeruginosa Conundrum
Kristi A. Traugott et al.
PHARMACOTHERAPY (2011)
Combination Antibiotic Therapy for Empiric and Definitive Treatment of Gram-Negative Infections Insights from the Society of Infectious Diseases Pharmacists
Natalie Boyd et al.
PHARMACOTHERAPY (2011)
Microbial Etiologies of Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia
Ronald N. Jones
CLINICAL INFECTIOUS DISEASES (2010)
Optimizing Empirical Antimicrobial Therapy for Infection due to Gram-Negative Pathogens in the Intensive Care Unit: Utility of a Combination Antibiogram
Jennifer Christoff et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2010)
Predictors of 30-day mortality among patients with Pseudomonas aeruginosa bloodstream infections:: Impact of delayed appropriate antibiotic selection
Thomas P. Lodise et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
A laboratory-based, hospital-wide, electronic marker for nosocomial infection - The future of infection control surveillance?
SE Brossette et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2006)
Pseudomonas aeruginosa bloodstream infection:: Importance of appropriate initial antimicrobial treatment
ST Micek et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Nosocomial bloodstream infections in US hospitals: Analysis of 24,179 cases from a prospective nationwide surveillance study
H Wisplinghoff et al.
CLINICAL INFECTIOUS DISEASES (2004)
Share Paper
